Emirates Health Services Showcases 19 Innovative Projects At Arab Health 2025

Emirates Health Services (EHS) is taking part in the 50th edition of Arab Health 2025, which starts Monday and runs until Jan. 30 at the Dubai World Trade Centre, under the theme "Future Health Now."

As the exclusive health services partner, EHS is showcasing 19 innovative projects, with 13 of them being revealed for the first time in the region and globally.

EHS is also focusing on "Family Health and Community Care," presenting three new projects, including two that are debuting both regionally and globally in partnership with international organizations, WAM reported.

Dr. Essam Al Zarooni, Acting Executive Director of the Medical Services Sector at EHS, emphasized that families are central to Emirati society and remain a top priority in the country's strategic plans.

Al Zarooni explained that the new projects are aimed at providing families with access to advanced healthcare services, improving their quality of life. He noted that EHS's participation in Arab Health 2025 reflects the leadership's vision of prioritizing the well-being of society.

He highlighted that investing in family health strengthens communities and ensures a better, sustainable lifestyle for all Emiratis.

A key project in this focus area is the "Usrati Bundle," developed with the Federal Authority for Identity, Citizenship, Customs and Port Security, and the Telecommunications and Digital Government Regulatory Authority.

The "My Family" platform offers a range of services for families, covering everything from marriage to child education. EHS has launched the "Premarital Genetic Tests," which screen 570 genes to identify potential hereditary diseases.

This service aims to educate couples about reproductive choices and promote healthy families for future generations. EHS is also presenting its groundbreaking "In-Utero Gene Editing" project, developed in collaboration with the Children's Hospital of Philadelphia.

The project focuses on correcting genetic mutations in the liver during pregnancy or shortly after birth. It aims to treat serious genetic disorders like Phenylketonuria (PKU) and Sickle Cell Anemia using gene editing delivered through lipid nanoparticles, which could improve patients' quality of life and reduce future suffering.

For the first time, EHS is introducing an early breast cancer detection program using artificial intelligence. In partnership with the Ministry of Education and the Ministry of Health and Prevention, this program screens teachers with the advanced "Bexa" device.

Known for its high accuracy in detecting tumors, the device enhances traditional mammography, improving early detection rates and survival outcomes.